Completed OBSERVATIONAL NCT02723396

Sleep, Awake & Move - Part I (SA&M-I)

Sleep & Move. Systematic Characterisation of Sleep Benefit in Parkinson's Disease. An Observational, Prospective Study

Sponsor: Ente Ospedaliero Cantonale, Bellinzona

Updated 9 times since 2017 Last updated: Feb 9, 2024 Started: Mar 16, 2016 Primary completion: May 31, 2019 Completion: Feb 9, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02723396, this observational or N/A phase trial focuses on Idiopathic Parkinson Disease and remains completed. Sponsored by Ente Ospedaliero Cantonale, Bellinzona, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2024 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Mar 2024 [monthly]

Unknown Status
Sep 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

Sep 2018 — Sep 2020 [monthly]

Recruiting
Jun 2018 — Sep 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ente Ospedaliero Cantonale, Bellinzona
Neurocenter of Southern Switzerland
Parkinson Schweiz
Penn State University

Data source: Neurocenter of Southern Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lugano, Switzerland